2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-07-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11405496 2023-07-01 2024-06-30 11405496 2024-06-30 11405496 2023-06-30 11405496 2022-07-01 2023-06-30 11405496 2023-06-30 11405496 2022-06-30 11405496 bus:Director1 2023-07-01 2024-06-30 11405496 core:WithinOneYear 2024-06-30 11405496 core:WithinOneYear 2023-06-30 11405496 core:AfterOneYear 2024-06-30 11405496 core:AfterOneYear 2023-06-30 11405496 bus:Micro-entities 2023-07-01 2024-06-30 11405496 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 11405496 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 11405496 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 11405496 bus:FullAccounts 2023-07-01 2024-06-30 11405496 bus:Chairman 2023-07-01 2024-06-30
COMPANY REGISTRATION NUMBER: 11405496
KC Healthcare Medical Limited
Filleted Unaudited Financial Statements
30 June 2024
KC Healthcare Medical Limited
Statement of Financial Position
30 June 2024
2024
2023
£
£
£
Fixed assets
1,105
1,548
-------
-------
Current assets
21,880
24,336
Prepayments and accrued income
337
677
--------
--------
22,217
25,013
Creditors: amounts falling due within one year
18,206
15,973
--------
--------
Net current assets
4,011
9,040
-------
--------
Total assets less current liabilities
5,116
10,588
Creditors: amounts falling due after more than one year
4,475
9,582
Accruals and deferred income
626
993
-------
--------
15
13
-------
--------
Capital and reserves
15
13
----
----
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
2. Directors' advances, credits and guarantees
During the previous year the Company made interest-free advances to the Directors and at the end of that period £3,301 was outstanding. A further loan of £372 was made this period and at the end of this period £3,673 was outstanding.
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 26 March 2025 , and are signed on behalf of the board by:
Dr K T Chmiel
Director
Company registration number: 11405496
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 115 Tile Cross Road, Birmingham, B33 0LS.